| CBD | cannabidiol |
| CBG | cannabigerol |
| CB1 | cannabinoid receptor type 1 |
| CB2 | cannabinoid receptor type 2 |
| ECS | endocannabinoid system |
| FSH | follicle-stimulating hormone |
| GnRH | gonadotropin-releasing hormone |
| HKII | hexokinase II |
| HPG axis | hypothalamic–pituitary–gonadal axis |
| IUGR | intrauterine growth restriction |
| LH | luteinizing hormone |
| mTOR | mammalian target of rapamycin |
| NCS | national cannabis survey |
| PCa | prostate cancer |
| PGI2 | prostacyclin receptor |
| PI3K | phosphatidylinositol-3-kinase |
| PUV | posterior urethral valve |
| SGA | small-of-gestational age |
| SIDS | sudden infant death syndrome |
| THC | δ9-tetrahydrocannabinol |
| VDAC1 | voltage-dependent anion channel 1 |